Novel investigational drugs active as single agents in multiple
Novel Functions of PXR: A Bioinformatic Approach
Novel Formulations and Dosing Strategies for 5-ASA
Novel Fluorescent Probes Detect Different Types Of CYP450
NOVEL FAK-SELECTIVE INHIBITORS
Novel Detoxification from Opiates
novel Biological treatments for systemic lupus erythematosus: current and Future modalities reviews
Novel Approaches to the Treatment of Systemic Anthrax
Novel Approaches to Neuroprotection
Novel approaches for the treatment of psychostimulant/opioid abuse
Novel Antipsychotic Agents and Their Implications for Forensic
Novel Antimicrobial Agents
Novel Anti-platelet Agents and Anticoagulants
Novel and emerging treatments
Novel analgesic combination of tramadol
Novel Agents on the Horizon for Cancer Therapy
Novel Agents for the Treatment of Chronic Lymphocytic Leukemia
NovaScreen Drugs of Abuse Cassette
Novartis Pharmaceuticals to Pay $390 Million
NOVARTIS OPHTHALMICS AND QLT ANNOUNCE FDA
